A detailed history of Cibc World Markets Corp transactions in Annexon, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 11,799 shares of ANNX stock, worth $37,166. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,799
Previous 21,667 45.54%
Holding current value
$37,166
Previous $41,000 31.71%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$1.38 - $2.73 $13,617 - $26,939
-9,868 Reduced 45.54%
11,799 $28,000
Q1 2025

May 13, 2025

BUY
$1.93 - $5.5 $41,817 - $119,168
21,667 New
21,667 $41,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $150M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.